{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:06:35Z","timestamp":1785355595922,"version":"3.55.0"},"reference-count":42,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R00-HL108157"],"award-info":[{"award-number":["R00-HL108157"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R56HL"],"award-info":[{"award-number":["R56HL"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["124073-01A1"],"award-info":[{"award-number":["124073-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HL 121510-01A1"],"award-info":[{"award-number":["R01 HL 121510-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["VISN-4 research grant"],"award-info":[{"award-number":["VISN-4 research grant"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>We assessed whether poor glycemic control is associated with an increase in myocardial fibrosis among adults with diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We studied 47 adults with type 2 diabetes and stratified them into three groups according to their hemoglobin A1c (HbA1c) level: &amp;lt;6.5% (group 1; n = 12), 6.5\u20137.5% (group 2; n = 20), and &amp;gt;7.5% (group 3; n = 15). Left ventricular (LV) mass was assessed using cardiac MRI. The extracellular volume fraction (ECVF), an index of myocardial fibrosis, was measured by using myocardial T1 mapping before and after the administration of a gadolinium-based contrast agent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Mean HbA1c was 5.84 \u00b1 0.16%, 6.89 \u00b1 0.14%, and 8.57 \u00b1 0.2% in groups 1, 2, and 3, respectively. LV mass was not significantly different between the groups. The myocardial ECVF was significantly greater in groups 2 (mean 27.6% [95% CI 24.8\u201330.3]) and 3 (27.6% [24.4\u201330.8]) than in group 1 (21.1% [17.5\u201324.7]; P = 0.015). After adjusting for age, sex, BMI, blood pressure, and estimated glomerular filtration rate, the myocardial ECVF was significantly greater in groups 2 (27.4% [24.4\u201330.4]) and 3 (28% [24.5\u201331.5]) than in group 1 (20.9% [17.1\u201324.6]; P = 0.0156, ANCOVA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>An increased myocardial ECVF, suggesting myocardial fibrosis, is independently associated with poor glycemic control among adults with diabetes. Further research should assess whether tight glycemic control can revert fibrosis to healthy myocardium or ameliorate it and its adverse clinical consequences.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-0324","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T15:25:52Z","timestamp":1531409152000},"page":"2019-2025","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":27,"title":["Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes"],"prefix":"10.2337","volume":"41","author":[{"given":"Ahmed","family":"Al-Badri","sequence":"first","affiliation":[{"name":"Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeba","family":"Hashmath","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett H.","family":"Oldland","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"},{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Miller","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"},{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuzaima","family":"Javaid","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"},{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer Ahmed","family":"Syed","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ansari","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Gaddam","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter R.","family":"Witschey","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"},{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Akers","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-5670","authenticated-orcid":false,"given":"Julio A.","family":"Chirinos","sequence":"additional","affiliation":[{"name":"Hospital of the University of Pennsylvania, Philadelphia, PA"},{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"2022031303350133700_B1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","article-title":"Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes","volume":"372","author":"Hayward","year":"2015","journal-title":"N Engl J Med"},{"key":"2022031303350133700_B2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"2022031303350133700_B3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"2022031303350133700_B4","first-page":"394","article-title":"Increased left ventricular extracellular volume and enhanced twist function in type 1 diabetic individuals","volume-title":"J Appl Physiol (1985)","author":"Vasanji","year":"2017"},{"key":"2022031303350133700_B5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/dc16-1889","article-title":"Association of cardiovascular risk factors and myocardial fibrosis with early cardiac dysfunction in type 1 diabetes: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"40","author":"Armstrong","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031303350133700_B6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11886-013-0449-0","article-title":"Role of cardiac MRI in diabetes","volume":"16","author":"Shah","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"2022031303350133700_B7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022031303350133700_B8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/HYPERTENSIONAHA.110.150250","article-title":"Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance","volume":"56","author":"Chirinos","year":"2010","journal-title":"Hypertension"},{"key":"2022031303350133700_B9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jmri.21119","article-title":"Optimization and validation of a fully-integrated pulse sequence for modified Look-Locker inversion-recovery (MOLLI) T1 mapping of the heart","volume":"26","author":"Messroghli","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"2022031303350133700_B10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004133","article-title":"Heart failure, left ventricular remodeling, and circulating nitric oxide metabolites","volume":"5","author":"Chirinos","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2022031303350133700_B11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jcmg.2016.10.007","article-title":"Myocardial fibrosis and cardiac decompensation in aortic stenosis","volume":"10","author":"Chin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022031303350133700_B12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcmg.2013.01.011","article-title":"T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique","volume":"6","author":"White","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022031303350133700_B13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12933-017-0557-z","article-title":"Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus","volume":"16","author":"Kozakova","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"2022031303350133700_B14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jacc.2013.01.053","article-title":"Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"61","author":"Shah","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022031303350133700_B15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCIMAGING.109.911438","article-title":"Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study","volume":"3","author":"Velagaleti","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022031303350133700_B16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2022031303350133700_B17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","article-title":"Evidence for cardiomyopathy in familial diabetes mellitus","volume":"60","author":"Regan","year":"1977","journal-title":"J Clin Invest"},{"key":"2022031303350133700_B18","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db09-1456","article-title":"Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy","volume":"59","author":"Huynh","year":"2010","journal-title":"Diabetes"},{"key":"2022031303350133700_B19","doi-asserted-by":"crossref","first-page":"H2109","DOI":"10.1152\/ajpheart.00157.2009","article-title":"Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes","volume":"297","author":"Ares-Carrasco","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031303350133700_B20","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2337\/db09-1800","article-title":"Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"2022031303350133700_B21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1394.004","article-title":"Mouse models for studies of cardiovascular complications of type 1 diabetes","volume":"1103","author":"Shen","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"2022031303350133700_B22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.yjmcc.2004.05.006","article-title":"Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity","volume":"37","author":"Zaman","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2022031303350133700_B23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02066486","article-title":"Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus","volume":"1","author":"Nunoda","year":"1985","journal-title":"Heart Vessels"},{"key":"2022031303350133700_B24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","article-title":"Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study","volume":"378","author":"Lind","year":"2011","journal-title":"Lancet"},{"key":"2022031303350133700_B25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00592-013-0455-0","article-title":"Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study","volume":"50","author":"Konduracka","year":"2013","journal-title":"Acta Diabetol"},{"key":"2022031303350133700_B26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00125-010-1682-3","article-title":"Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis","volume":"53","author":"von Bibra","year":"2010","journal-title":"Diabetologia"},{"key":"2022031303350133700_B27","doi-asserted-by":"crossref","first-page":"e003643","DOI":"10.1161\/CIRCIMAGING.115.003643","article-title":"Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus","volume":"9","author":"Leung","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022031303350133700_B28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0188-4409(00)00264-2","article-title":"Left ventricular diastolic dysfunction secondary to hyperglycemia in patients with type II diabetes","volume":"32","author":"S\u00e1nchez-Barriga","year":"2001","journal-title":"Arch Med Res"},{"key":"2022031303350133700_B29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0975-3583.89805","article-title":"Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function","volume":"2","author":"Patil","year":"2011","journal-title":"J Cardiovasc Dis Res"},{"key":"2022031303350133700_B30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2022031303350133700_B31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"2022031303350133700_B32","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1152\/ajpendo.00497.2011","article-title":"Activation of mTOR\/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation","volume":"302","author":"Kim","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303350133700_B33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1582-4934.2008.00547.x","article-title":"Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy","volume":"13","author":"Ma","year":"2009","journal-title":"J Cell Mol Med"},{"key":"2022031303350133700_B34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.RES.49.6.1268","article-title":"Myocardial composition and function in diabetes. The effects of chronic insulin use","volume":"49","author":"Regan","year":"1981","journal-title":"Circ Res"},{"key":"2022031303350133700_B35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2011.02.023","article-title":"Association of diabetes mellitus with myocardial collagen accumulation and relaxation impairment in patients with dilated cardiomyopathy","volume":"92","author":"Sakakibara","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031303350133700_B36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02766802","article-title":"A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension","volume":"12","author":"Kawaguchi","year":"1997","journal-title":"Heart Vessels"},{"key":"2022031303350133700_B37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/heartjnl-2016-310790","article-title":"Heart failure with preserved ejection fraction: controversies, challenges and future directions","volume":"104","author":"Zakeri","year":"2018","journal-title":"Heart"},{"key":"2022031303350133700_B38","doi-asserted-by":"crossref","first-page":"4786925","DOI":"10.1155\/2016\/4786925","article-title":"Assessment of left ventricular structural remodelling in patients with diabetic cardiomyopathy by cardiovascular magnetic resonance","volume":"2016","author":"Shang","year":"2016","journal-title":"J Diabetes Res"},{"key":"2022031303350133700_B39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCHEARTFAILURE.113.000920","article-title":"Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus","volume":"8","author":"Parry","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2022031303350133700_B40","first-page":"S132","article-title":"Hypoglycemia and cardiovascular risks","volume-title":"Diabetes Care","author":"Frier","year":"2011"},{"key":"2022031303350133700_B41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejheart.2008.05.013","article-title":"The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy","volume":"10","author":"McAlister","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2022031303350133700_B42","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/dc07-0141","article-title":"Thiazolidinediones and heart failure: a teleo-analysis","volume":"30","author":"Singh","year":"2007","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-0324","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/9\/2019\/552468\/dc180324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/9\/2019\/552468\/dc180324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T08:10:08Z","timestamp":1647159008000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/41\/9\/2019\/40706\/Poor-Glycemic-Control-Is-Associated-With-Increased"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,7,12]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-0324","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]}}}